A fellowship-trained Mohs surgeon and board-certified dermatologist, this physician focuses on the treatment of complex and high-risk skin cancers, particularly in immunocompromised populations such as transplant recipients and patients with hematologic malignancies. Her clinical work integrates Mohs micrographic surgery with advanced reconstructive techniques, laser procedures, and longitudinal management of cutaneous oncology patients. She has led specialized programs dedicated to high-risk skin cancer and has extensive experience treating aggressive and recurrent disease requiring multidisciplinary coordination.

Her career combines academic medicine, clinical research, and industry leadership. She previously held faculty and leadership roles at a major academic medical center, including directing a dermatology clinical research unit and a high-risk skin cancer program, and later served in executive roles within a biotechnology organization overseeing clinical development and device strategy. She has contributed to clinical trials and a body of peer-reviewed research in cutaneous oncology. In addition to her clinical and research work, she provides expert consultation in dermatologic and oncologic matters, including medico-legal case review and deposition testimony.